论文部分内容阅读
目的探讨氟桂利嗪单用及联用血塞通治疗老年偏头痛患者的临床疗效。方法 78例老年偏头痛患者作为研究对象,按随机抽签方式分成治疗组与对照组,每组39例。治疗组应用氟桂利嗪联合血塞通治疗,对照组单纯应用氟桂利嗪治疗。对比两组患者的治疗效果以及偏头痛发作次数。结果治疗组治疗总有效率为94.87%,高于对照组的76.92%,差异具有统计学意义(P<0.05)。治疗组偏头痛发作次数为(4.05±0.75)次/月,少于对照组的(9.72±1.46)次/月,差异具有统计学意义(P<0.05)。结论氟桂利嗪联用血塞通治疗老年偏头痛患者的临床疗效优于氟桂利嗪单用方案,其可有效减少患者偏头痛发作次数,可作为老年偏头痛治疗理想用药方案。
Objective To investigate the clinical efficacy of flunarizine alone and in combination with Xuesaitong in the treatment of senile migraine. Methods Seventy-eight elderly patients with migraine were divided into treatment group and control group by random sampling, with 39 cases in each group. The treatment group was treated with flunarizine combined with Xuesaitong, while the control group was treated with flunarizine alone. The two groups of patients were compared for the treatment and the number of migraine attacks. Results The total effective rate of the treatment group was 94.87%, which was higher than 76.92% of the control group, the difference was statistically significant (P <0.05). The number of migraine attacks in the treatment group was (4.05 ± 0.75) times per month, less than the control group (9.72 ± 1.46) times per month, the difference was statistically significant (P <0.05). Conclusion Flunarizine combined with Xuesaitong in the treatment of migraine elderly patients is better than flunarizine single-use program, which can effectively reduce the number of migraine attacks in patients with migraine can be used as the ideal drug regimen.